AXT-3001

N/A

Report date: 2023/03/06 14:28:47
NME

Base Information

Drug NameAXT-3001
Drug Alias NameAXT-3001
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionUbiquitin-protein ligases inhibitors
TargetsUbiquitin-protein ligases
Therapy Area/IndicationsSolid tumoursLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAstoc Biomedical (Tianjin) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAstoc Biomedical (Tianjin) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A